Excipients

Oct 09, 2008
ePT--the Electronic Newsletter of Pharmaceutical Technology
The European Fine Chemicals Group (EFCG) and the International Pharmaceutical Excipents Council of Europe (IPEC Europe) announced the formation of  a European Pharmaceutical Excipients Certification Project to develop advocacy and stakeholder management in Europe and to give advice to two European working teams as part of an effort to develop a certification program for manufacturers and distributors of pharmaceutical excipients.
Oct 01, 2008
Pharmaceutical Technology
By Pharmaceutical Technology Editors
Securing the integrity of the excipient supply chain is a crucial task in ensuring the overall pharmaceutical supply chain. The authors outline excipient-control strategies and practices for the manufacture, distribution, and receipt of excipients.
Jul 02, 2008
Pharmaceutical Technology
By Pharmaceutical Technology Editors
Clear labels for substances that can be used as excipients, APIs, or both are critical to end-product use.
Jul 02, 2008
Pharmaceutical Technology
A roundtable with John Doney, Jiao Yang, Hans Baer, and Elena Draganoiu.
May 02, 2008
Pharmaceutical Technology
By Pharmaceutical Technology Editors
The less complex nature of excipient manufacturers, as compared with API manufactures, carries many benefits.
Apr 02, 2008
Pharmaceutical Technology
Excipient producers and industry observers share their perspectives on innovation for excipients.
Apr 02, 2008
Pharmaceutical Technology
Moderate growth is projected for the global excipients market. Excipient producers target blends and new grades for improving functionality and performance.
Apr 02, 2008
Pharmaceutical Technology
By Pharmaceutical Technology Editors
A changing regulatory environment is on the horizon for excipient suppliers and users.
Mar 02, 2008
Pharmaceutical Technology
By Pharmaceutical Technology Editors
Mannitol is the most commonly used bulking agent in freeze-drying formulation design. The benefit of using mannitol is that it crystallizes during freezing and permits drying processes at higher product temperatures, and thus with higher sublimation rates relative to purely amorphous systems (1). Mannitol, however, is known to form different crystalline modifications which compromises reproducibility of product characteristics and storage stability due to phase transformations (2, 3).
Jan 02, 2008
Pharmaceutical Technology
By Pharmaceutical Technology Editors
Pharmaceutical manufacturers often avoid putting new excipients in their formulations for fear of more regulatory oversight. IPEC has a solution.
native1_300x100
lorem ipsum